"That said, the company need to start turning the seminars/webinars and industry presentations/collaborations into actions not just more talk..."
Personally I think the TF deal is a bigger action than any of the other well known asx cancer stocks have achieved so far. Then soon after the MD Anderson deal. Then great safety and efficacy in the ptx100 trial.
ptx is definitely a doer. And CellPryme-A could attract deals very quickly.
But my guess is that TF will get their cheque book out or make a script offer.
PTX Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
